SUBSCRIBE
SUBSCRIBE
News   Business

Eugene Melnyk Plans New Drug Firm if Biovail Corporation Fight Fails; New Company Would Be Called Trimel Pharmaceuticals

June 26, 2008 | 
1 min read
TORONTO, June 25 (Reuters) - Biovail Corp founder Eugene Melnyk plans to start a new drug company if his attempt to replace Biovail's board of directors fails. Click on link below to access full story.
Startups
MORE ON THIS TOPIC
A mother affection flat round icon, editable download
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
May 20, 2026
 · 
2 min read
 · 
Gabrielle Masson
Email envelope with warning sign on white background
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
May 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Parabilis follows hefty Regeneron deal with IPO push
May 20, 2026
 · 
13 min read
 · 
Editorial Team
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
May 20, 2026
 · 
1 min read
 · 
Jef Akst